A Jakubowska, D Rozkrut, A Antoniou, U Hamann, R J Scott, L McGuffog, S Healy, O M Sinilnikova, G Rennert, F Lejbkowicz, A Flugelman, I L Andrulis, G Glendon, H Ozcelik, OCGN, M Thomassen, M Paligo, P Aretini, SWE-BRCA, J Kantala, B Aroer, A von Wachenfeldt, A Liljegren, N Loman, K Herbst, U Kristoffersson, R Rosenquist, P Karlsson, M Stenmark-Askmalm, B Melin, K L Nathanson, S M Domchek, T Byrski, T Huzarski, J Gronwald, J Menkiszak, C Cybulski, P Serrano, A Osorio, T R Cajal, M Tsitlaidou, J Benítez, M Gilbert, HEBON, M Rookus, C M Aalfs, I Kluijt, J L Boessenkool-Pape, H E J Meijers-Heijboer, J C Oosterwijk, C J van Asperen, M J Blok, M R Nelen, A M W van den Ouweland, C Seynaeve, R B van der Luijt, P Devilee, EMBRACE, D F Easton, S Peock, D Frost, R Platte, S D Ellis, E Fineberg, D G Evans, F Lalloo, R Eeles, C Jacobs, J Adlard, R Davidson, D Eccles, T Cole, J Cook, A Godwin, B Bove, GEMO Study Collaborators, D Stoppa-Lyonnet, V Caux-Moncoutier, M Belotti, C Tirapo, S Mazoyer, L Barjhoux, N Boutry-Kryza, P Pujol, I Coupier, J-P Peyrat, P Vennin, D Muller, J-P Fricker, L Venat-Bouvet, O Th Johannsson, C Isaacs, R Schmutzler, B Wappenschmidt, A Meindl, N Arnold, R Varon-Mateeva, D Niederacher, C Sutter, H Deissler, S Preisler-Adams, J Simard, P Soucy, F Durocher, G Chenevix-Trench, J Beesley, X Chen, KConFab, T Rebbeck, F Couch, X Wang, N Lindor, Z Fredericksen, V S Pankratz, P Peterlongo, B Bonanni, S Fortuzzi, B Peissel, C Szabo, P L Mai, J T Loud, J Lubinski, on behalf of CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer